FDA launches 2026 Accelerated AI Pathway Pilot to evaluate AI-generated evidence in drug submissions
No AI-designed drug has received FDA approval yet.
#687Bojan Tunguz@TUNGUZWhat people don’t realize about the recent phenomenal success of the metabolic drugs is that ALL of them were designed/created *pre* the current AI boom. We have not even started to scratch the surface of what is possible with these new tools. But the promises are unbelievable.
Chubby♨️@kimmonismusOver 200 AI-designed drugs are now in clinical trials worldwide. Not a single one has been FDA-approved. The FDA just launched a pilot program to work out how it should even evaluate AI-generated evidence in drug submissions, selecting 10 companies for an expedited, interactive review process. The drugs got ahead of the regulatory framework. That's the actual state of AI pharma right now.
Source: https://intuitionlabs.ai/articles/fda-accelerated-ai-pathway-pilot-phase-1
Chubby♨️@kimmonismusOver 200 AI-designed drugs are now in clinical trials worldwide. Not a single one has been FDA-approved. The FDA just launched a pilot program to work out how it should even evaluate AI-generated evidence in drug submissions, selecting 10 companies for an expedited, interactive review process. The drugs got ahead of the regulatory framework. That's the actual state of AI pharma right now.